Caring Brands Inc. announces two new patents to enhance hair follicle enzyme activity, supporting its Hair Enzyme Booster product.
Quiver AI Summary
Caring Brands Inc. has announced the issuance of two new U.S. patents that enhance its proprietary methods and compositions aimed at increasing enzymatic activity in hair follicles, which supports the effectiveness of its Hair Enzyme Booster product. Granted by the U.S. Patent and Trademark Office in January 2026, these patents focus on technologies that boost sulfotransferase enzyme activity, crucial for improving topical hair loss treatments. This expansion of the company’s intellectual property strengthens its market position and underpins its strategy to develop enzyme-based solutions for a wider patient demographic. CEO Dr. Glynn Wilson emphasized the significance of these patents as a validation of their technology and a means to fortify their competitive advantage. The company is also planning to launch additional products in the coming years while continuing to advance its proprietary technology and expand distribution.
Potential Positives
- The issuance of two new U.S. patents enhances Caring Brands Inc.'s intellectual property portfolio, providing exclusive protections for their Hair Enzyme Booster technology.
- The newly granted patents support the company's ability to commercialize enzyme-based solutions that may improve treatment responsiveness in a broader patient population.
- This development reflects a significant milestone for the company, validating the scientific foundation behind their proprietary technology in hair and skin health.
- Caring Brands plans to launch a total of 5 new products in the next 2 years, indicating growth potential and strategic expansion in their market offerings.
Potential Negatives
- While the issuance of new patents is generally positive, it could indicate that the company is still heavily reliant on developing new intellectual property to remain competitive, which may pose risks if these innovations do not succeed in the market.
- The forward-looking statements section raises concerns regarding potential risks and uncertainties that could materially affect future performance, which may create skepticism among investors about the company's projections.
- The mention of additional products planned for launch over the next two years could suggest that the current product offerings may not be sufficient to meet revenue expectations, indicating possible financial vulnerability.
FAQ
What are the new patents issued to Caring Brands Inc. for?
The new patents enhance enzymatic activity in hair follicles, supporting the Hair Enzyme Booster product's effectiveness.
When were the patents granted to Caring Brands Inc.?
The patents were granted by the United States Patent and Trademark Office in January 2026.
How does the Hair Enzyme Booster improve hair loss treatments?
The Hair Enzyme Booster increases sulfotransferase enzyme activity, which improves the efficacy of topical hair loss treatments.
What is the future product development plan for Caring Brands?
Caring Brands intends to launch five new products over the next two years while pursuing additional licensing opportunities.
Who is the CEO of Caring Brands Inc.?
The CEO of Caring Brands Inc. is Dr. Glynn Wilson, who emphasized the importance of the new patents for the company.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CABR Hedge Fund Activity
We have seen 1 institutional investors add shares of $CABR stock to their portfolio, and 0 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 10,893 shares (+inf%) to their portfolio in Q4 2025, for an estimated $9,344
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Fort Pierce, FL, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Caring Brands Inc. (Nasdaq: CABR) today announced the issuance of two new United States patents covering proprietary methods and compositions designed to enhance enzymatic activity in hair follicles, further strengthening the Company’s intellectual property portfolio supporting its Hair Enzyme Booster product.
The newly issued patents, granted by the United States Patent and Trademark Office in January 2026, relate to technologies that increase sulfotransferase enzyme activity to improve the efficacy of topical hair loss treatments. These patents expand Caring Brands’ exclusive protection around mechanisms that are central to the Hair Enzyme Booster, which is currently generating revenue through direct sales in the United States and via international licensees. The newly granted patents support the Company’s ability to commercialize enzyme-based solutions that may improve treatment responsiveness in a broader patient population.
Dr. Glynn Wilson, Chief Executive Officer of Caring Brands Inc., said, “The issuance of these two patents represents an important milestone for Caring Brands and further validates the scientific foundation behind our Hair Enzyme Booster technology. Strengthening our intellectual property position in this area enhances our competitive moat and supports our long-term strategy of building a portfolio of differentiated, patented products in hair and skin health.”
Caring Brands continues to execute on its strategy of developing, protecting, and commercializing proprietary technologies with meaningful clinical and commercial potential. The Company expects to provide additional updates as it advances product development, expands distribution, and evaluates further opportunities to leverage its growing patent portfolio.
About Caring Brands
Caring Brands Inc. has a growing portfolio of unique, patented, and clinically validated products for skin and hair growth. The Company intends to launch a total of 5 products over the next 2 years in addition to in-licensing additional products. Management has a successful track record of strategic acquisitions, rapid product development, IP development and product licensing. Revenues from the sales of Hair Enzyme Booster for the treatment of hair loss, and Photocil for the treatment of psoriasis and vitiligo, are currently being generated by direct sales in the US and licensees in India. Additional product opportunities include CB-101 for the treatment of eczema, NoStingz, a sunscreen that prevents jellyfish stings.
Contact :
Brian S John
Chief Investment Officer
(561) 896-7616
Forward-Looking Statements
This communication contains forward-looking statements regarding Caring Brands, Inc., including, the anticipated timing of studies and the results and benefits thereof. You can generally identify forward-looking statements by the use of forward-looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “explore,” “evaluate,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” or “will,” or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are based on each of the Company’s current plans, objectives, estimates, expectations, and intentions and inherently involve significant risks and uncertainties, many of which are beyond our control. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties and other risks and uncertainties affecting Caring Brands, Inc.. Moreover, other risks and uncertainties of which the combined company is not currently aware may also affect each of the companies’ forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. Investors are cautioned that forward-looking statements are not guarantees of future performance. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements and reflect the views stated therein with respect to future events at such dates, even if they are subsequently made available by Caring Brands, Inc. on its website or otherwise. Caring Brands, Inc. undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made.